VERT-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VERT-002, covering 2025-07-02 to 2025-07-02. Get the full timeline:
Most recent: Clinical Trial Update: FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations [Phase 1, Phase 2]